23
Lung cancer

Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Embed Size (px)

Citation preview

Page 1: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Lung cancer

Page 2: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Epidemiology

• Incidence: Lung cancer is the most common cancer in the world

• Mortality: is the leading cause of cancer deaths in both men and women

• RO:-males: 1.-females: 4.

Page 3: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Epidemiology-USA

Page 4: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Epidemiology-USA

Page 5: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Epidemiology-USA

Page 6: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Etiology (risk factors)

I. Environmental1. Smoking is the primary risk factor for lung

cancer accounting for 90% of cases in men and 70% in women

• It is a risk factor for both NSCLC (squamous cell carcinoma, adenocarcinoma, large cell carcinoma) and SCLC

Page 7: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

• In the US: Adenocarcinoma has been more common than squamous cell carcinoma in women since the 1950s and became the most common lung cancer diagnosis in men in 1990.

• There are many theories that may explain a relative decrease in squamous and small cell carcinomas and the increase in adenocarcinomas. The introduction of filter cigarettes in the mid-1950s may have contributed:

1. by allowing smaller carcinogens to be deposited in the lung periphery.

2. may have determined smokers to take larger puffs and retain smoke longer to compensate for the lower nicotine yield

Plus, smoking low-tar filter cigarettes may increase the rate of adenocarcinoma because these cigarettes have a higher nitrate content, which has been shown to produce adenocarcinoma in laboratory animals.

Page 8: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

• Men who smoke one pack a day increase their risk 10 times compared with non-smokers.

• Men who smoke two packs a day increase their risk more than 25 times compared with non-smokers

• The lifetime risk of developing lung cancer in smokers is approximately 10%

• Cancer risk decreases slowly after quitting: 40% of newly diagnosed lung cancer occurs in former smokers (median abstinence duration 9 years)

Page 9: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Etiology2. The second most important environmental risk factor is Rn

(Radon)=a radioactive gas-from rocks-represents 40% from the background radiation-it is deposited in the airways-deposition in airways increased if bound to aerosols (for

example smoke); smoking increases deposition 25 times3. Asbestos- increases risk both for lung cancer and

mesothelioma (of the pleura or peritoneum)4. Exposure to radiatione.g. radiotherapy for breast cancer

Page 10: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Etiology5. Industrial pollutants (Ni, Be)II. Genetic predispositionWhy not all people who smoke develop lung cancer?- genetic polymorphism or deletion of genes of enzymes

playing a role in detoxification of polycyclic aromatic hydrocarbons found in tobacco smoke

Page 11: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Classification

• Non-small cell lung cancer=NSCLC (80%)- consists of 3 main types: – Squamous cell carcinoma– Adenocarcinoma– Large cell carcinoma

• Small cell lung cancer=SCLC (=oat cell cancer) (20%)

-different behavior (more aggressive)-early metastases

Page 12: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Special subtype: bronchioloalveolar carcinoma• Rare: 2-9% of primary lung cancers• Related to adenocarcinoma• At first it is non-invasive tumor (carcinoma in situ), but eventually

can produce metastases• Tumor cells spread along the alveoles=>Produces dyspnea in a restrictive (not obstructive) way• Smoking is a risk factor, but it is less important than in other histological subtypes• Radiologic patterns:peripheral solitary nodule (43%); consolidation (30%), or diffuse disease (27%)

Page 13: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Extension

• Local:-invasion of the big mediastinal vessels-invasion of the pericardium-invasion of the laryngeal recurrent nerves-invasion of the pleura-invasion of chest wall (e.g. Pancoast tumor)

Page 14: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Pancoast tumor=superior sulcus tumor=malignant neoplasm of the thorax inlet with invasion

of the chest wall and involvement of the brachial plexus and cervical sympathetic nerves.

Symptoms: - severe pain in the shoulder region radiating toward

the axilla, scapula and along the ulnar aspect of the muscles of the hand

- atrophy of hand and arm muscles- Bernard-Horner syndrome (compression of

sympathetic chain)- compression of the subclavian vein with oedema

Page 15: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Extension• Lymphatic--hilar-mediastinal(drainage crosses to the

other side to)-scalene, supraclavicular

Page 16: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Extension• Metastases--brain-bone-liver

Page 17: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Symptomsa) Endobronchial tumors-cough, obstructive dyspnea, hemoptisis, obstructive

pneumoniab) Peripheral tumors-longer asymptomatic evolution-pleural invasion=>pleuritic pain and cough; restrictive

dyspnea; pulmonary abscess formationc) Compression/invasion of mediastinal/thoracic structures by

primary tumor or lymph nodes-tracheal obstruction; dysphagia; dysphonia; paralysis of a

hemidiaphragm by invasion of a phrenic nerve; superior vena cava obstruction; dyspnea by pleural exudate/or transsudate;

Page 18: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Symptomsd) Extrathoracic metastases-brain-liver-bone-suprarenals (asthenia)e) General symptoms (weight loss, asthenia)f) Paraneoplastic syndromes

Page 19: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Diagnosis• Chest radiography• Chest and upper abdominal CT or PET-CT(MRI not good for mobile organs such as the lung)• Endobronchial biopsy or transbronchial biopsy• Mediastinoscopy or thoracoscopy with biopsy for tumors not

biopsiable bronchoscopically• Pleural liquid, if present, must be tested for malignant cells-

important for staging and thus treatment• Brain MRI• Pulmonary function testing

Page 20: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Treatment-NSCLC• Resectable tumor=> lobectomy/unilateral pneumonectomy

plus mediastinal lymphadenectomy+/- adjuvant chemotherapy or radiotherapy• Unresectable tumor=> concomitant chemoradiation with or

without reevaluation for surgery• Metastatic lung cancer=>chemotherapy• Endobronchial obstruction=> palliative desobstruction with:-stent-LASER-brachytherapy or external beam RT-photodynamic therapy• Superior vena cava obstruction: -emergency palliative external beam radiotherapy or stent

Page 21: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Treatment-SCLCLIMITED-STAGE DISEASE=SCLC which is limited to a hemithorax

and can be encompassed in one tolerable radiation field• Stage I disease (only 5% of patients) (true stage I is after

extensive testing, including mediastinoscopic lymphadenectomy)=> lobectomy

• Other limited disease=> chemoradiation

EXTENSIVE-STAGE DISEASE• Chemotherapy

• All patients who are in complete or partial response: prophylactic cranial irradiation

Page 22: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Screening

• Stage I lung cancer can be diagnosed using annual low dose CT scans

• No screening programs implemented yet; studies ongoing

• Warning: 1000 CTs of chest/abdomen=> 1 radio-induced cancer

Page 23: Lung cancer. Epidemiology Incidence: Lung cancer is the most common cancer in the world Mortality: is the leading cause of cancer deaths in both men and

Questions

• What are the risk factors of lung cancer?• What are the symptoms of lung cancer?• How is non-small cell lung cancer treated?